<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medical Device Courses | aca | Mentions</title>
	<link>https://medicaldevicecourses.com/members/aca/activity/mentions/</link>
	<atom:link href="https://medicaldevicecourses.com/members/aca/activity/mentions/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed mentioning aca.</description>
	<lastBuildDate>Sat, 16 May 2026 12:13:51 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">b88c92f20b5863e8a40b8c2f3e0c59eb</guid>
				<title>Ehab B. replied to the topic  &#034;Navigating Design History and Project Delivery&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/41569/</link>
				<pubDate>Mon, 23 Feb 2026 01:20:53 -0500</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/aca/' rel="nofollow ugc">@aca</a> your challenging of the idea that the DHF is the PM&#8217;s ultimate deliverable. If a PM&#8217;s mindset becomes to produce a perfect DHF, they risk placing too much focus on compliance instead of acting as a proper strategic leader&#8230;. &nbsp; <a href="https://medicaldevicecourses.com/forums/project-management-process-and-medical-device-development/navigating-design-history-and-project-delivery/#post-23206" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">69e31eb4de9e52eef9c7920db2beb3c1</guid>
				<title>Ehab B. replied to the topic  &#034;PM Problem Involving Pre-clinical Trial Results and Market Entry Deadlines&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/40704/</link>
				<pubDate>Mon, 16 Feb 2026 01:33:43 -0500</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/aca/' rel="nofollow ugc">@aca</a> You raise an interesting issue here, as this is not just a technical setback but a design control and traceability event. With a high risk device like the stent, dissolution rate is not a secondary parameter, due to its&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/introduction-to-project-management/pm-problem-involving-pre-clinical-trial-results-and-market-entry-deadlines/#post-23116" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>